Trial · NCT04859517
Trial comparisons15
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 15 of 15
Download this page as JSON| Comparison | Source |
|---|---|
| ADG20 IM - Cohort B vs Placebo IM - Cohort B: Percentage of Participants With at Least 1 COVID-19 Related Medically Attended Outpatient Visit (PrEP) | Trial comparisons |
| ADG20 IM - Cohort B vs Placebo IM - Cohort B: Percentage of Participants With a COVID-19 Related Hospitalization (PrEP) | Trial comparisons |
| ADG20 IM - Cohort A vs Placebo IM - Cohort A: Percentage of Participants With Asymptomatic SARS-CoV-2 Infection as Determined by Serology (PEP) | Trial comparisons |
| ADG20 IM - Cohort A vs Placebo IM - Cohort A: All-Cause Mortality (PEP) | Trial comparisons |
| ADG20 IM - Cohort A vs Placebo IM - Cohort A: Percentage of Participants With RT-PCR Confirmed Symptomatic COVID-19 (PEP) | Trial comparisons |
| ADG20 IM - Cohort B vs Placebo IM - Cohort B: All-Cause Mortality (PrEP) | Trial comparisons |
| ADG20 IM - Cohort A vs Placebo IM - Cohort A: Percentage of Participants With a COVID-19 Related Hospitalization (PEP) | Trial comparisons |
| ADG20 IM - Cohort A vs Placebo IM - Cohort A: Percentage of Participants With SARS-CoV-2 Infection (Asymptomatic or Symptomatic) as Determined by Positive RT-PCR or Serology (PEP) | Trial comparisons |
| ADG20 IM - Cohort A vs Placebo IM - Cohort A: Percentage of Participants With at Least 1 COVID-19 Related Medically Attended Outpatient Visit (PEP) | Trial comparisons |
| ADG20 IM - Cohort B vs Placebo IM - Cohort B: COVID-19 Related Mortality (PrEP) | Trial comparisons |
| ADG20 IM - Cohort B vs Placebo IM - Cohort B: Percentage of Participants With RT-PCR Confirmed Symptomatic COVID-19 (PrEP) | Trial comparisons |
| ADG20 IM - Cohort B vs Placebo IM - Cohort B: Percentage of Participants With Asymptomatic SARS-CoV-2 Infection as Determined by Serology (PrEP) | Trial comparisons |
| ADG20 IM - Cohort A vs Placebo IM - Cohort A: Percentage of Participants With Asymptomatic SARS-CoV-2 Infection as Determined by RT-PCR (PEP) | Trial comparisons |
| ADG20 IM - Cohort A vs Placebo IM - Cohort A: COVID-19 Related Mortality (PEP) | Trial comparisons |
| ADG20 IM - Cohort A vs Placebo IM - Cohort A: Percentage of Participants With RT-PCR Confirmed Symptomatic COVID-19 (PEP) | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04859517/comparisons